Skip to main content
Log in

How to increase return on investment of the intensive care pharmacist – fear of flying

  • Clinical Commentary
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Rudis MI, Brandl KM (2000) Position paper on critical care pharmacy services. Society of Critical Care Medicine and American College of Clinical Pharmacy Task Force on Critical Care Pharmacy Services. Crit Care Med 28:3746–3750

    Article  PubMed  CAS  Google Scholar 

  2. Broyles JE, Brown RO, Vehe KL, Nolly RJ, Luther RW (1991) Pharmacist interventions improve fluid balance in fluid-restricted patients requiring parenteral nutrition. DICP 25:119–122

    PubMed  CAS  Google Scholar 

  3. Devlin JW, Holbrook AM, Fuller HD (1997) The effect of ICU sedation guidelines and pharmacist interventions on clinical outcomes and drug cost. Ann Pharmacother 31:689–695

    PubMed  CAS  Google Scholar 

  4. Simpson JH, Lynch R, Grant J, Alroomi L (2004) Reducing medication errors in the neonatal intensive care unit. Arch Dis Child Fetal Neonatal Ed 89:F480–482

    Article  PubMed  CAS  Google Scholar 

  5. Vogel Kahmann I, Burki R, Denzler U, Hofler A, Schmid B, Splisgardt H (2003) [Incompatibility reactions in the intensive care unit. Five years after the implementation of a simple "colour code system"]. Anaesthesist 52:409–412

    Article  PubMed  Google Scholar 

  6. Kaye J, Ashline V, Erickson D, Zeiler K, Gavigan D, Gannon L, Wynne P, Cooper J, Kittle W, Sharma K, Morton J (2000). Critical care bug team: a multidisciplinary team approach to reducing ventilator-associated pneumonia. Am J Infect Control 28:197–201

    Article  PubMed  CAS  Google Scholar 

  7. Calabrese AD, Erstad BL, Brandl K, Barletta JF, Kane SL, Sherman DS (2001) Medication administration errors in adult patients in the ICU. Intensive Care Med 27:1592–1598

    Article  PubMed  CAS  Google Scholar 

  8. Rudis MI, Sikora CA, Angus E, Peterson E, Popovich J, Hyzy R, Zarowitz BJ (1997) A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients. Crit Care Med 25:575–583

    Article  PubMed  CAS  Google Scholar 

  9. Dager WE, Albertson TE (1992) Impact of therapeutic drug monitoring of intravenous theophylline regimens on serum theophylline concentrations in the medical intensive care unit. Ann Pharmacother 26:1287–1291

    PubMed  CAS  Google Scholar 

  10. Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JL, Bates, DW (1999) Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 282:267–270

    Article  PubMed  CAS  Google Scholar 

  11. Lazarou J, Pomeranz BH, Coery PN (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279:1200–1205

    Article  PubMed  CAS  Google Scholar 

  12. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359–1367

    Article  PubMed  Google Scholar 

  13. Kane SL, Weber RJ, Dasta JF (2003) The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med 29:691–698

    PubMed  Google Scholar 

  14. McMullin ST, Hennenfent JA, Ritchie DJ, Huey HY, Lonergan TP, Schaiff RA, Tonn ME, Bailey TC (1999) A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions. Arch Intern Med 59:2306–2309

    Article  Google Scholar 

  15. Dell. Available at http://www.dell.de. Accessed 18.10.2005

  16. Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957–2963

    Article  PubMed  Google Scholar 

  17. Klopfer JD, Einarson TR (1990) Acceptance of pharmacists' suggestions by prescribers: a literature review. Hosp Pharm 25:830–832, 834–836

    PubMed  CAS  Google Scholar 

  18. Nurminen, M. (1997) [Slaves of the p-value?]. Duodecim 113:277–80

    PubMed  CAS  Google Scholar 

  19. Lilly: Financial Ratios. Available at http://investor.lilly.com/ratios.cfm. Accessed 24.01.2005

  20. Lycos: Financial Ratios. Available at http://finance.lycos/qc/research/marketguide.aspx?pg=fin&symbols=NYSE:PFE. Accessed 13.01.2005

Download references

Acknowledgements

We are indebted for his assistance in preparing this manuscript to Professor Ross J. Baldessarini, MD, Harvard Medical School, Boston, Massachusetts, who (even without the prior necessity for financial analyses) has for many years been active in the integration of psychiatric specialists, PharmD clinical pharmacists and their trainees into the Psychopharmacology Service that he directs at the McLean Division of Massachusetts General Hospital.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael Hartmann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hartmann, M., Meier-Hellmann, A. How to increase return on investment of the intensive care pharmacist – fear of flying. Intensive Care Med 32, 511–515 (2006). https://doi.org/10.1007/s00134-006-0072-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-006-0072-2

Keywords

Navigation